TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. North America Cardiac Marker Market Landscape

4.1 Overview

4.2 PEST Analysis

5. North America Cardiac Marker Market - Key Market Dynamics

5.1 North America Cardiac Marker Market - Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Cardiovascular Diseases

5.2.2 Surge in Demand for Point-of-Care Cardiac Testing Kits

5.3 Market Restraints

5.3.1 Strict Validation and Technical Issues Related to Sample Collection and Storage

5.4 Market Opportunities

5.4.1 Investments in Cardiovascular Sector

5.5 Future Trends

5.5.1 Ongoing Research in Use of Exosomes as CVD Biomarkers

5.6 Impact analysis

6. North America Cardiac Marker Market Analysis

6.1 North America Cardiac Marker Market Revenue (US$ Million), 2021-2031

7. North America Cardiac Marker Market Analysis - by Product Type

7.1 Analyzers

7.1.1 Overview

7.1.2 Analyzers: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents and Kits

7.2.1 Overview

7.2.2 Reagents and Kits: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Cardiac Marker Market Analysis - by Biomarker Type

8.1 Troponin

8.1.1 Overview

8.1.2 Troponin: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

8.2 Creatine Kinase-MB

8.2.1 Overview

8.2.2 Creatine Kinase-MB: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Myoglobin

8.3.1 Overview

8.3.2 Myoglobin: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

8.4 B-Type Natriuretic Peptide

8.4.1 Overview

8.4.2 B-Type Natriuretic Peptide: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Cardiac Marker Market Analysis - by Indication

9.1 Congestive Heart Failure

9.1.1 Overview

9.1.2 Congestive Heart Failure: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Myocardial Infraction

9.2.1 Overview

9.2.2 Myocardial Infraction: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Acute Coronary Syndrome

9.3.1 Overview

9.3.2 Acute Coronary Syndrome: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Cardiac Marker Market Analysis - by End User

10.1 Hospitals

10.1.1 Overview

10.1.2 Hospitals: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

10.2 Diagnostic Laboratories

10.2.1 Overview

10.2.2 Diagnostic Laboratories: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Point-of-Care Testing Facilities

10.3.1 Overview

10.3.2 Point-of-Care Testing Facilities: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Others

10.4.1 Overview

10.4.2 Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Cardiac Marker Market - Country Analysis

11.1 North America

11.1.1 North America Cardiac Marker Market Breakdown by Countries

11.1.2 North America Cardiac Marker Market Revenue and Forecast and Analysis - by Country

11.1.2.1 United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

11.1.2.1.1 United States: North America Cardiac Marker Market Breakdown by Product Type

11.1.2.1.2 United States: North America Cardiac Marker Market Breakdown by Biomarker Type

11.1.2.1.3 United States: North America Cardiac Marker Market Breakdown by Indication

11.1.2.1.4 United States: North America Cardiac Marker Market Breakdown by End User

11.1.2.2 Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

11.1.2.2.1 Canada: North America Cardiac Marker Market Breakdown by Product Type

11.1.2.2.2 Canada: North America Cardiac Marker Market Breakdown by Biomarker Type

11.1.2.2.3 Canada: North America Cardiac Marker Market Breakdown by Indication

11.1.2.2.4 Canada: North America Cardiac Marker Market Breakdown by End User

11.1.2.3 Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

11.1.2.3.1 Mexico: North America Cardiac Marker Market Breakdown by Product Type

11.1.2.3.2 Mexico: North America Cardiac Marker Market Breakdown by Biomarker Type

11.1.2.3.3 Mexico: North America Cardiac Marker Market Breakdown by Indication

11.1.2.3.4 Mexico: North America Cardiac Marker Market Breakdown by End User

12. Industry Landscape

12.1 Overview

12.2 Recent Development Strategies

12.2.1 Overview

13. Cardiac Marker Market-Industry Landscape

13.1 Overview

13.2 Organic Growth Strategies

13.2.1 Overview

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 F. Hoffmann-La Roche Ltd

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Thermo Fisher Scientific Inc

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Beckman Coulter Inc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bio-Rad Laboratories Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Creative Diagnostics

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Diazyme Laboratories, Inc.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 bioMerieux SA

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 HyTest Ltd.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 QuidelOrtho Corp

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Cardiac Marker Market Segmentation

Table 2. Available POC Products in the US

Table 3. Exosomes as CVD Biomarkers

Table 4. United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type

Table 5. United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Biomarker Type

Table 6. United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 7. United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 8. Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type

Table 9. Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Biomarker Type

Table 10. Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 11. Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 12. Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type

Table 13. Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Biomarker Type

Table 14. Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 15. Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 16. Recent Development Activities in the Cardiac Marker Market

Table 17. Recent Organic Growth Strategies in the Cardiac Marker Market

Table 18. Glossary of Terms, North America Cardiac Marker Market

LIST OF FIGURES

Figure 1. North America Cardiac Marker Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Cardiac Marker Market Revenue (US$ Million), 2021-2031

Figure 5. North America Cardiac Marker Market Share (%) - by Product Type, 2023 and 2031

Figure 6. Analyzers: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Reagents and Kits: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. North America Cardiac Marker Market Share (%) - by Biomarker Type, 2023 and 2031

Figure 9. Troponin: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Creatine Kinase-MB: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Myoglobin: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 12. B-Type Natriuretic Peptide: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. North America Cardiac Marker Market Share (%) - by Indication, 2023 and 2031

Figure 15. Congestive Heart Failure: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Myocardial Infraction: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Acute Coronary Syndrome: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. North America Cardiac Marker Market Share (%) - by End User, 2023 and 2031

Figure 20. Hospitals: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 21. Diagnostic Laboratories: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Point-of-Care Testing Facilities: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. North America Cardiac Marker Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 25. United States: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 26. Canada: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. Mexico: North America Cardiac Marker Market - Revenue and Forecast to 2031 (US$ Million)